Lipid Analysis Devices Market : Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2028

 

Measurements of excessive plasma cholesterol, triglycerides, or low levels of high-density lipoprotein are made using lipid analysis equipment (HDL). Blood lipid levels must be measured in order to monitor the risk of cardiovascular disease. For the identification of Tangier disease, hyperlipidemia, hypertriglyceridemia, hypercholesterolemia, and hyperlipoproteinemia, a lipid analysis instrument is used. A lipid analysis device may be used as a point-of-care device or incorporated in clinics. In comparison to clinical analyzers, point-of-care devices have a larger range of applications because of their affordability, accuracy, usability, and speed of result generation. The market for lipid analysis devices is driven by technology improvements, the rising frequency of aberrant lipid levels, and the rising incidence of lipid disorders. However, clinical-based analyzers are expensive and subject to strict, time-consuming regulations.

The development of mass spectrometry technology and the expanding use of lipidomics in biomedical sciences are credited with driving the industry. Premium product cost, however, restrains the market's expansion for Lipid Analysis Devices Market. Analysis of lipids is a part of the developing biological science subject known as lipidomics. System-level quantification and identification of various cellular lipid networks, pathways, and interactions with other proteins and moieties are all part of the field of Lipid Analysis Devices Market. Over the course of the forecast period, market growth is anticipated to be driven by factors such as the need for precise disease diagnosis, the rise in demand for personalized medicine, technological advancements in lipidomics, and significant investments in R&D from both the public and private sectors.

A significant portion of inpatient point-of-care technologies, including biosensors, lab-on-a-chip, smartphone apps, and other wearable devices, are contributed by the healthcare industry, which is encouraging the market expansion of the worldwide POC Lipid Analysis Devices Market. The aging population, rising rates of diabetes, heart disease, and obesity, as well as rising healthcare awareness, are all contributing to the market's expansion.

Key Players

Some of the key companies in the market for lipid analysis devices include Polymer Technology Systems, Inc., Jan Pharmaceutical Corporation, Alere, F. Hoffmann-La Roche Ltd., Acon Laboratories, Inc., and Cholestech Corporation. The techniques like merging